Author/Authors :
Emre Tahaoglu Ali نويسنده Department of Obstetrics and Gynecology, Gazi Yasargil
Research and Training Hospital, Elazig Yolu 12, Km Diyarbakir,
Turkey , Bakir Sait نويسنده Diyarbakir Obstetrics and Gynecology Hospital,
Baglar-Diyarbakir, Turkey , Erdogdu Emre نويسنده Diyarbakir Obstetrics and Gynecology Hospital,
Baglar-Diyarbakir, Turkey , Dane Cem نويسنده Haseki Research and Training Hospital, Istanbul,
Turkey
Abstract :
Objectives The aim of this study was to investigate the benefits
of the newly revised “The international federation of gynecology and
obstetrics (FIGO), 2009” sytem and whether there was a difference in new
system comparison to 1988 FİGO staging sytem for endometrial carcinoma.
Methods A total of 132 patients who underwent complete surgical staging
for endometrial cancer were enrolled retrospectively. Those patients’
overall survival and disease free survival were compared with 1988 and
2009 staging system. Results The five year overall survival (OS) rates
for patients with 1988 FIGO stage 1 and 2 were 97% and 100%,
respectively. In 2009 system, the OS rates for 1 and 2 were 97% and
100%, respectively. There was no statistically significant differences
between stage 1 and stage 2 for OS rates in 1988 and 2009 as well.
Conclusions The newly revised system could be less complex for
understanding, but it does not discriminate survival rates better,
especially in earlier stages. A new staging system and uniform surgical
staging could be discussed.
